261 related articles for article (PubMed ID: 28363942)
1. USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.
Luo K; Li Y; Yin Y; Li L; Wu C; Chen Y; Nowsheen S; Hu Q; Zhang L; Lou Z; Yuan J
EMBO J; 2017 May; 36(10):1434-1446. PubMed ID: 28363942
[TBL] [Abstract][Full Text] [Related]
2. FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer.
Hou J; Wang L
PLoS One; 2012; 7(5):e36252. PubMed ID: 22590527
[TBL] [Abstract][Full Text] [Related]
3. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Pei H; Li L; Fridley BL; Jenkins GD; Kalari KR; Lingle W; Petersen G; Lou Z; Wang L
Cancer Cell; 2009 Sep; 16(3):259-66. PubMed ID: 19732725
[TBL] [Abstract][Full Text] [Related]
4. FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP.
Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S
Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
6. The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.
Park JM; Yang SW; Zhuang W; Bera AK; Liu Y; Gurbani D; von Hoyningen-Huene SJ; Sakurada SM; Gan H; Pruett-Miller SM; Westover KD; Potts MB
PLoS Biol; 2021 Jun; 19(6):e3001281. PubMed ID: 34077419
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications and stress adaptation: the paradigm of FKBP51.
Rein T
Biochem Soc Trans; 2020 Apr; 48(2):441-449. PubMed ID: 32318709
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats.
Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496
[TBL] [Abstract][Full Text] [Related]
9. InterAKTions with FKBPs--mutational and pharmacological exploration.
Fabian AK; März A; Neimanis S; Biondi RM; Kozany C; Hausch F
PLoS One; 2013; 8(2):e57508. PubMed ID: 23469007
[TBL] [Abstract][Full Text] [Related]
10. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway.
McClurg UL; Summerscales EE; Harle VJ; Gaughan L; Robson CN
Oncotarget; 2014 Aug; 5(16):7081-92. PubMed ID: 25216524
[TBL] [Abstract][Full Text] [Related]
12. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.
Liu X; Tian X; Wang F; Ma Y; Kornmann M; Yang Y
Eur J Cancer; 2014 Sep; 50(13):2251-62. PubMed ID: 24953335
[TBL] [Abstract][Full Text] [Related]
13. MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway.
Wang T; Chen G; Ma X; Yang Y; Chen Y; Peng Y; Bai Z; Zhang Z; Pei H; Guo W
Cell Death Dis; 2019 Feb; 10(3):153. PubMed ID: 30770779
[TBL] [Abstract][Full Text] [Related]
14. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
[TBL] [Abstract][Full Text] [Related]
16. A molecular link between AKT regulation and chemotherapeutic response.
Dibble CC; Manning BD
Cancer Cell; 2009 Sep; 16(3):178-80. PubMed ID: 19732717
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
Zhang Z; Han H; Rong Y; Zhu K; Zhu Z; Tang Z; Xiong C; Tao J
J Exp Clin Cancer Res; 2018 Nov; 37(1):291. PubMed ID: 30486896
[TBL] [Abstract][Full Text] [Related]
18. FKBP51 regulates decidualization through Ser473 dephosphorylation of AKT.
Wei M; Gao Y; Lu B; Jiao Y; Liu X; Cui B; Hu S; Sun L; Mao S; Dong J; Yan L; Chen Z; Zhao Y
Reproduction; 2018 Mar; 155(3):283-295. PubMed ID: 29363568
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.
Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T
Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563
[TBL] [Abstract][Full Text] [Related]
20. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Clin Cancer Res; 2005 May; 11(9):3433-8. PubMed ID: 15867245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
